Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Testosterone: Functions and Regulation

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....

Signs of Puberty

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Graph Convolutional Networks Enable Fast Hemorrhagic Stroke Monitoring With Electrical Impedance Tomography.

IEEE transactions on bio-medical engineering·2025

Same author

[Chronic prostatitis/chronic pelvic pain syndrome].

Urologie (Heidelberg, Germany)·2023

Same author

[Urinary diversion for acute epididymitis : Transurethral or suprapubic catheter?]

Urologie (Heidelberg, Germany)·2022

Same author

Structural engineering from an inverse problems perspective.

Proceedings. Mathematical, physical, and engineering sciences·2022

Same author

Linguistic validation and cognitive assessment of the French version of the Acute Cystitis Symptom Score questionnaire.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022

Same author

[Complicated urinary tract infections].

Der Urologe. Ausg. A·2020

Same journal

Der Urologe. Ausg. A·2022

Same journal

Der Urologe. Ausg. A·2022

Same journal

Der Urologe. Ausg. A·2022

Same journal

Der Urologe. Ausg. A·2022

Same journal

Der Urologe. Ausg. A·2022

Same journal

Der Urologe. Ausg. A·2022

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 22, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

[Testosterone therapy].

T Diemer¹, A Hauptmann², F M E Wagenlehner²

¹Klinik und Poliklinik für Urologie, Kinderurologie und Andrologie, Universitätsklinikum Gießen und Marburg GmbH, Standort Gießen, Justus-Liebig-Universität Gießen, Rudolf-Buchheim-Straße 7, 35385, Gießen, Deutschland. Thorsten.Diemer@chiru.med.uni-giessen.de.

Der Urologe. Ausg. A

|April 13, 2016

Summary

This summary is machine-generated.

Testosterone replacement therapy is a safe and effective treatment for hypogonadism and erectile dysfunction. Evolving guidelines and improved formulations enhance its use in urological practice, with urologists central to patient care and monitoring.

Keywords:

Erectile dysfunction Hormone replacement therapy Hypogonadism Late-onset hypogonadism Testosterone

More Related Videos

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Related Experiment Videos

Last Updated: Mar 22, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Area of Science:

Endocrinology and Urology
Hormone Replacement Therapy

Background:

Testosterone replacement therapy (TRT) has evolved from a therapy with initial safety concerns to a well-established treatment modality.
Concerns regarding complications, especially in older patients, have largely been alleviated by long-term data.
TRT is now recognized as a valuable supportive treatment for conditions like hypogonadism and erectile dysfunction.

Purpose of the Study:

To review the current status and established role of testosterone therapy in urological practice.
To highlight the advancements in testosterone preparations and available treatment guidelines.
To emphasize the importance of urologists in managing testosterone deficiency, including monitoring for adverse events.

Main Methods:

Review of established medical literature and clinical practice regarding testosterone therapy.
Analysis of current guidelines for indications, contraindications, and monitoring protocols.
Discussion of pharmaceutical advancements improving drug delivery and patient compliance.

Main Results:

Testosterone therapy is considered safe and effective, with initial safety concerns largely unsubstantiated.
Numerous testosterone preparations are available, with recent developments enhancing ease of use.
Established guidelines provide clear standards for TRT, aiding in its safe and effective application.

Conclusions:

Testosterone therapy is a routine and valuable treatment in urology for hypogonadism and erectile dysfunction.
Urologists play a crucial role in patient management, risk assessment, and monitoring of TRT.
Ongoing vigilance regarding cardiovascular and prostate health is essential for optimal patient outcomes.